Cargando…
Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)
The coronavirus SARS-CoV-2 has highlighted the criticality of an accurate and rapid diagnosis in order to contain the spread of the virus. Knowledge of the viral structure and its genome is essential for diagnosis development. The virus is still quickly evolving and the global scenario could easily...
Autores principales: | Dorta-Gorrín, Alexis, Navas-Méndez, Jesús, Gozalo-Margüello, Mónica, Miralles, Laura, García-Hevia, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299269/ https://www.ncbi.nlm.nih.gov/pubmed/37373381 http://dx.doi.org/10.3390/ijms241210233 |
Ejemplares similares
-
Chemical Trends in Sample Preparation for Nucleic Acid Amplification Testing (NAAT): A Review
por: Lee, Soo Min, et al.
Publicado: (2023) -
432. Qualitative Differentiation of Genital Ulcer Disease Etiology via Nucleic Acid Amplification Testing (NAAT)
por: McGowin, Chris L, et al.
Publicado: (2019) -
Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort
por: Davies, Bethan, et al.
Publicado: (2018) -
Mobile nucleic acid amplification testing (mobiNAAT) for Chlamydia trachomatis screening in hospital emergency department settings
por: Shin, D. J., et al.
Publicado: (2017) -
1346. Ruling out TB in New York City: Are Two NAATs (Nucleic Acid Amplification Testing) Enough?
por: Greendyke, William G, et al.
Publicado: (2019)